June 2020 - Page 118 of 383

NASDAQ Companies - June 22, 2020

Guardant Health Presents Data at AACR Virtual Annual Meeting II Showing Liquid Biopsy Highly Accurate in Detecting Early-Stage Colorectal Cancer

REDWOOD CITY, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, presents new […]

NASDAQ Companies - June 22, 2020

Mersana Therapeutics Presents Preclinical Data from its Innovative Dolasynthen and Immunosynthen ADC Platforms at American Association for Cancer Research 2020 Virtual Annual Meeting

Preclinical data on XMT-1592, a NaPi2b-targeted site-specific and homogeneous Dolasynthen ADC, demonstrate excellent activity, tolerability and pharmacokineticsPreclinical data on multiple […]

NYSE Companies - June 22, 2020

Stereotaxis to be Added to the Russell 2000® and Russell 3000® Indexes

ST. LOUIS, June 22, 2020 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the […]

NYSE Companies - June 22, 2020

Duke Realty Commences Tender Offer for 3.875% Senior Notes Due 2022

INDIANAPOLIS, June 22, 2020 (GLOBE NEWSWIRE) — Duke Realty Corporation (NYSE: DRE), a leading industrial property REIT, announced today that […]

TSX Venture News - June 22, 2020

BriaCell Announces Presentation of Clinical and Scientific Findings at AACR Annual Meeting

Preliminary safety and efficacy data is being presented today from the clinical trials of Bria-IMT™ alone or in combination with […]

NASDAQ Companies - June 22, 2020

Flushing Bank Receives Grant Money from Federal Home Loan Bank of New York’s (FHLBNY) Small Business Recovery Grant Program to Assist Local Small Businesses and Non-Profit Organizations

UNIONDALE, N.Y., June 22, 2020 (GLOBE NEWSWIRE) — Flushing Financial Corporation (the “Company”) (Nasdaq: FFIC), the parent holding company for […]

NASDAQ Companies - June 22, 2020

Turning Point Therapeutics’ Lead Drug Candidate Repotrectinib Increases Effectiveness of KRAS-G12C and MEK Inhibitors in Preclincal KRAS Cancer Models

SAN DIEGO, June 22, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation […]

NASDAQ Companies - June 22, 2020

Genocea to Present Data that Reveal New Understanding of ATLASTM-Identified InhibigenTM Biology at AACR Virtual Annual Meeting II

Inhibigens (inhibitory antigens) are detrimental an otherwise protective immunotherapyInhibigens alter the tumor microenvironment and drive tumor hyperprogressionInhibigens abolish both [...]

NASDAQ Companies - June 22, 2020

ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at the 2020 American Association for Cancer Research Virtual Annual Meeting II

SOUTH SAN FRANCISCO, Calif., June 22, 2020 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company […]

NASDAQ Companies - June 22, 2020

Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series

EMERYVILLE, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and […]